Target intelligence / Profile preview

Notch signaling pathway (Notch 1-HES axis) (Notch 1-HES pathway)

Target
Notch 1-HES pathway
Molecular classification
Receptor (Notch 1), Transcription factor (HES1), Signaling pathway (Notch signaling pathway), Other (Intercellular signaling pathway)
01

Overview

The Notch signaling pathway (Notch 1-HES axis) is a highly conserved cell-cell communication pathway essential for proper embryonic development, cell fate specification, proliferation, and tissue homeostasis. Notch 1, a single-pass transmembrane receptor, upon ligation, undergoes proteolytic cleavage releasing its intracellular domain (NICD), which translocates to the nucleus and complexes with transcription factors to regulate genes such as HES1, a basic helix-loop-helix (bHLH) transcriptional repressor. Dysregulation of this pathway is implicated in diverse diseases including cancer, cardiovascular disorders, and immune dysfunction. Inhibition of the pathway, particularly with γ-secretase inhibitors, is under clinical investigation, but toxicity due to the pathway’s roles in normal tissue homeostasis remains a major therapeutic challenge.

Other names
Notch 1 signaling pathwayNotch 1-HES1 pathwayNotch 1 intracellular domain-HES axis
02

Mechanism of action

Inhibit γ-secretase to block Notch receptor cleavage and nuclear translocation of Notch intracellular domain Antibodies block receptor or ligand to prevent activation of receptor-mediated signaling Down-regulate Notch target gene expression (e.g., HES1 repression)

03

Biological functions

Cell fate determinationCell proliferationCell differentiationApoptosisEmbryonic developmentTissue homeostasisSignal transduction
04

Disease associations

Cancer (oncogenic and tumor suppressor roles depending on context)Cardiovascular disease (e.g., congenital heart disease, bicuspid aortic valve)Immune disorders (autoimmunity, graft-vs-host disease)Neurodevelopmental disordersOther (e.g., vascular diseases, fibrosis)
05

Safety considerations

Gastrointestinal toxicity (e.g., diarrhea, nausea, vomiting)On-target toxicities due to Notch’s critical roles in normal tissue homeostasisHematopoietic toxicity (impacts on immune cells)Potential for selection of drug-resistant clonesImpaired tissue repair and regeneration
06

Interacting drugs

γ-Secretase inhibitors (GSIs; e.g., MK-0752, RO4929097, MRK-003)

2 more in the full profile.

07

Biomarkers

NOTCH1 expression level or mutation (as in certain cancers)HES1 expression as a readout of Notch pathway activationCirculating NICD (rarely; mainly in research)Additional pathway effectors (HEY1/2, related Notch targets)

Beyond the preview

Go deeper on Notch signaling pathway (Notch 1-HES axis) (Notch 1-HES pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Notch signaling pathway (Notch 1-HES axis) (Notch 1-HES pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call